Waldenstrom Macroglobulinemia Immunophenotypes and its Relation with others Hematopathies
Keywords:
lymphoma, non-hodgkin; immunoglobulin m; immunophenotyping
Abstract
Waldenstrom's Macroglobulinemia (MW) is characterized by a type of mature B-cell non-Hodking lymphoma with proliferation of lymphoplasmocyte elements in the bone marrow and presence of monoclonal immunoglobulin M gamopathy. Given the rarity of the disease, the wide spectrum of hematopathies can mask the diagnosis of this disease. Therefore, the identification of immunophenotypes is one of the main medical challenges for making an early diagnosis. The present study brings a retrospective and descriptive essay, based on systematic reviews around the main biological markers used to make the diagnosis of patients with Waldenstrom's Macroglobulinemia, through the active search for original articles in the Pubmed, Science direct, Scielo, UpToDate and Portal Capes databases. Six articles with a specific theme were selected, categorized according to the differential diagnoses of Waldenstrom's Macroglobulinemia.
Downloads
How to Cite
References
A Hoffbrand, P V; Moss (2013) Fundamentos em Hematologia. 254.
Shahrzad Jalali, Stephen Ansell (2016) Bone marrow microenvironment in Waldenstrom's Macroglobulinemia. 29(2), 148-155.
Yuya Kunisaki, Ingmar Bruns, Christoph Scheiermann, Jalal Ahmed, Sandra Pinho, Dachuan Zhang, Toshihide Mizoguchi, Qiaozhi Wei, Daniel Lucas, Keisuke Ito, Jessica Mar, Aviv Bergman, Paul Frenette (2013) Arteriolar niches maintain haematopoietic stem cell quiescence. 502(7473), 637-643.
Wei Wang, Pei Lin (2020) Lymphoplasmacytic lymphoma and Waldenström macroglobulinaemia: clinicopathological features and differential diagnosis. 52(1), 6-14.
P; Advani, A; Paulus, S Ailawadhi (2019) Updates in prognostication and treatment of Waldenström's macroglobulinemia. 12(4), 179-188.
Genevieve Crane, Elise Jeffery, Sean Morrison (2017) Adult haematopoietic stem cell niches. 17(9), 573-590.
Claudio Tripodo, Sabina Sangaletti, Pier Piccaluga, Sonam Prakash, Giovanni Franco, Ivan Borrello, Attilio Orazi, Mario Colombo, Stefano Pileri (2011) The bone marrow stroma in hematological neoplasms-a guilty bystander. 8(8), 456-466.
Victor Andrade (2009) Aspectos morfológicos da infiltração da medula óssea por condições exibindo diferenciação plasmocitária e gamopatia monoclonal. 31(4), 273-279.
La; Calheiros, M Almeida, E Kimura, J Bigonha, G; Colleoni, M; Chauffaille, M Yamamoto (2010) Immunophenotypic characterization of plasma cells in patients with multiple myeloma. 46(4), 301-307.
S Rajkumar, Meletios Dimopoulos, Antonio Palumbo, Joan Blade, Giampaolo Merlini, María-Victoria Mateos, Shaji Kumar, Jens Hillengass, Efstathios Kastritis, Paul Richardson, Ola Landgren, Bruno Paiva, Angela Dispenzieri, Brendan Weiss, Xavier Leleu, Sonja Zweegman, Sagar Lonial, Laura Rosinol, Elena Zamagni, Sundar Jagannath, Orhan Sezer, Sigurdur Kristinsson, Jo Caers, Saad Usmani, Juan Lahuerta, Hans Johnsen, Meral Beksac, Michele Cavo, Hartmut Goldschmidt, Evangelos Terpos, Robert Kyle, Kenneth Anderson, Brian Durie, Jesus Miguel (2014) International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. 15(12), e538-e548.
S Treon, Y; Cao, L; Xu, G; Yang, X; Liu, Z Hunter (2014) Somatic mutations in MYD88 and CXCR4 are determinants of clinical presentation and overall survival in Waldenström macroglobulinemia. 123(18), 2791-2796.
Celso Rodrigues, Matheus Gonçalves, Maura Ikoma, Irene Lorand-Metze, André Pereira, Danielle Farias, Maria Chauffaille, Rony Schaffel, Eduardo Ribeiro, Talita Rocha, Valeria Buccheri, Yuri Vasconcelos, Vera Figueiredo, Carlos Chiattone, Mihoko Yamamoto (2016) Erratum to "Diagnosis and treatment of chronic lymphocytic leukemia: Recommendations from the Brazilian Group of Chronic Lymphocytic Leukemia" [Rev Bras Hematol Hemoter. 2016;38(4):346-357]. 39(1), 93-94.
Meletios Dimopoulos, Efstathios Kastritis (2019) How I treat Waldenström macroglobulinemia. 134(23), 2022-2035.
Jeevan Sekhar, Kristen Sanfilippo, Qin Zhang, Kathryn Trinkaus, Ravi Vij, Daniel Morgensztern (2012) Waldenström macroglobulinemia: a Surveillance, Epidemiology, and End Results database review from 1988 to 2005. 53(8), 1625-1626.
E; Kastritis, V Leblond, M Dimopoulos, E; Kimby, P; Staber, M Kersten, A; Tedeschi, C Buske (2018) Waldenström's macroglobulinaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. 29(4), iv41-iv50.
Stéphanie Poulain, Christophe Roumier, Aurélie Venet-Caillault, Martin Figeac, Charles Herbaux, Guillemette Marot, Emmanuelle Doye, Elisabeth Bertrand, Sandrine Geffroy, Frédéric Lepretre, Olivier Nibourel, Audrey Decambron, Eileen Boyle, Aline Renneville, Sabine Tricot, Agnès Daudignon, Bruno Quesnel, Patrick Duthilleul, Claude Preudhomme, Xavier Leleu (2016) Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia. 22(6), 1480-1488.
F Sa; Alhumaydhi (2019) Proteomics insights into the pathology and prognosis of chronic lymphocytic leukemia. 40(4), 317-327.
Pascal Schneider, Fabienne Mackay, Véronique Steiner, Kay Hofmann, Jean-Luc Bodmer, Nils Holler, Christine Ambrose, Pornsri Lawton, Sarah Bixler, Hans Acha-Orbea, Danila Valmori, Pedro Romero, Christiane Werner-Favre, Rudolph Zubler, Jeffrey Browning, Jürg Tschopp (1999) BAFF, a Novel Ligand of the Tumor Necrosis Factor Family, Stimulates B Cell Growth. 189(11), 1747-1756.
Sherine Elsawa, Anne Novak, Steven Ziesmer, Luciana Almada, Lucy Hodge, Deanna Grote, Thomas Witzig, Martin Fernandez-Zapico, Stephen Ansell (2011) Comprehensive analysis of tumor microenvironment cytokines in Waldenstrom macroglobulinemia identifies CCL5 as a novel modulator of IL-6 activity. 118(20), 5540-5549.
Mark Bustoros, Romanos Sklavenitis-Pistofidis, Prashant Kapoor, Chia-Jen Liu, Efstathios Kastritis, Saurabh Zanwar, Geoffrey Fell, Jithma Abeykoon, Kalvis Hornburg, Carl Neuse, Catherine Marinac, David Liu, Jenny Soiffer, Maria Gavriatopoulou, Cody Boehner, Joseph Cappuccio, Henry Dumke, Kaitlen Reyes, Robert Soiffer, Robert Kyle, Steven Treon, Jorge Castillo, Meletios Dimopoulos, Stephen Ansell, Lorenzo Trippa, Irene Ghobrial (2019) Progression Risk Stratification of Asymptomatic Waldenström Macroglobulinemia. 37(16), 1403-1411.
Morie Gertz (2019) Waldenström macroglobulinemia: 2019 update on diagnosis, risk stratification, and management. 94(2), 266-276.
Robert Kyle, Joanne Benson, Dirk Larson, Terry Therneau, Angela Dispenzieri, Shaji Kumar, L Melton, S Rajkumar (2012) Progression in smoldering Waldenström macroglobulinemia: long-term results. 119(19), 4462-4466.
Hong Zou, Rong Yang, Zhong‐xian Liao, Tian‐di Qin, Ping Chen, Bei‐ying Zhang, Ying‐ping Cao, Hui‐fang Huang (2019) Serum markers in the differential diagnosis of Waldenstrom macroglobulinemia and other IgM monoclonal gammopathies. 33(3), e22827.
B Paiva, M Montes, R García-Sanz, E Ocio, J Alonso, N De Las Heras, F Escalante, R Cuello, A De Coca, J Galende, J Hernández, M Sierra, A Martin, E Pardal, A Bárez, J Alonso, L Suarez, T González-López, J Perez, A Orfao, M-B Vidríales, J San Miguel (2014) Multiparameter flow cytometry for the identification of the Waldenström's clone in IgM-MGUS and Waldenström's Macroglobulinemia: new criteria for differential diagnosis and risk stratification. 28(1), 166-173.
Daeun Ryu, Hee Kim, Je-Gun Joung, Hae-Ock Lee, Joon Bae, Seok Kim, Haesu Kim, Woong-Yang Park, Kihyun Kim (2016) Comprehensive genomic profiling of IgM multiple myeloma identifies IRF4 as a prognostic marker. 7(30), 47127-47133.
T Mouhieddine, L Weeks, I Ghobrial (2019) Monoclonal gammopathy of undetermined significance. 133(23), 2484-2494.
Suping Zhang, Thomas Kipps (2014) The Pathogenesis of Chronic Lymphocytic Leukemia. 9(1), 103-118.
M Hallek, B Cheson, D Catovsky, F Caligaris-Cappio, G Dighiero, H Dohner (2008) Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International workshop on chronic lymphocytic leukemia updating the National cancer institute-working group 1996 guidelines. 111(12), 5446-5456.
Irene Lorand-Metze (2005) LLC: critérios diagnósticos, imunofenotipagem e diagnóstico diferencial. 27(4), 233-235.
Valter Gattei, Pietro Bulian, Maria Del Principe, Antonella Zucchetto, Luca Maurillo, Francesco Buccisano, Riccardo Bomben, Michele Dal-Bo, Fabrizio Luciano, Francesca Rossi, Massimo Degan, Sergio Amadori, Giovanni Del Poeta (2008) Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia. 111(2), 865-873.
(2017) WHO Classification: Tumours of the Haematopoietic and Lymphoid Tissues (2008). 2, 885-887.
Xinfang Yu, Wei Li, Qipan Deng, Ling Li, Eric Hsi, Ken Young, Mingzhi Zhang, Yong Li (2018) MYD88 L265P Mutation in Lymphoid Malignancies. 78(10), 2457-2462.
Steven Treon, Lian Xu, Guang Yang, Yangsheng Zhou, Xia Liu, Yang Cao, Patricia Sheehy, Robert Manning, Christopher Patterson, Christina Tripsas, Luca Arcaini, Geraldine Pinkus, Scott Rodig, Aliyah Sohani, Nancy Harris, Jason Laramie, Donald Skifter, Stephen Lincoln, Zachary Hunter (2012) MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia. 367(9), 826-833.
Sushant Vinarkar, Neeraj Arora, Sourav Chowdhury, Kallol Saha, Biswajoy Pal, Mayur Parihar, Vivek Radhakrishnan, Anupam Chakrapani, Shilpa Bhartia, Saurabh Bhave, Mammen Chandy, Reena Nair, Deepak Mishra (2019) MYD88 and CXCR4 Mutation Profiling in Lymphoplasmacytic Lymphoma/Waldenstrom's Macroglobulinaemia. 35(1), 57-65.
Sarah Ondrejka, Jeffrey Lin, Doug Warden, Lisa Durkin, James Cook, Eric Hsi (2013) MYD88 L265P Somatic Mutation. 140(3), 387-394.
M Varettoni, L Arcaini, S Zibellini, E Boveri, S Rattotti, R Riboni, A Corso, E Orlandi, M Bonfichi, M Gotti, C Pascutto, S Mangiacavalli, G Croci, V Fiaccadori, L Morello, M Guerrera, M Paulli, M Cazzola (2013) Prevalence and clinical significance of the somatic MYD88 (L265P) mutation in Waldenstrom's macroglobulinemia and related lymphoid neoplasms. 121(13), 2522-2528.
S Poulain, C Roumier, A Venet-Caillault, M Figeac, C Herbaux, G Marot, E Doye, E Bertrand, S Geffroy, F Lepretre, O Nibourel, A Decambron, Mary Boyle, E Renneville, A Tricot, S Daudignon, A Quesnel, B Duthilleul, P Preudhomme, C Leleu, X (2016) Genomic Landscape of CXCR4 Mutations in Waldenström Macroglobulinemia. 22(6), 1480-1487.
Leomar Ballester, Sanam Loghavi, Rashmi Kanagal-Shamanna, Bedia Barkoh, Pei Lin, L Medeiros, Rajyalakshmi Luthra, Keyur Patel (2016) Clinical Validation of a CXCR4 Mutation Screening Assay for Waldenstrom Macroglobulinemia. 16(7), 395-403.e1.
Barbara Muz, Nilantha Bandara, Cedric Mpoy, Jennifer Sun, Kinan Alhallak, Feda Azab, Buck Rogers, Abdel Azab (2020) CXCR4-targeted PET imaging using 64Cu-AMD3100 for detection of Waldenström Macroglobulinemia. 21(1), 52-60.
S Milanesi, M Locati, E Borroni (2020) Aberrant CXCR4 Signaling at Crossroad of WHIM Syndrome and Waldenstrom's Macroglobulinemia. 21(16), 5696.
Published
2023-03-16
Issue
Section
License
Copyright (c) 2023 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.